Cargando…

Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8(+) T Cell Epitopes

Influenza peptide antigens coding for conserved T cell epitopes have the capacity to induce cross-protective influenza-specific immunity. Short peptide antigens used as a vaccine, however, often show poor immunogenicity. In this study, we demonstrate that whole-inactivated influenza virus (WIV) acts...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soema, Peter C., Rosendahl Huber, Sietske K., Willems, Geert-Jan, Jacobi, Ronald, Hendriks, Marion, Soethout, Ernst, Jiskoot, Wim, de Jonge, Jørgen, van Beek, Josine, Kersten, Gideon F. A., Amorij, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861146/ https://www.ncbi.nlm.nih.gov/pubmed/29593747 http://dx.doi.org/10.3389/fimmu.2018.00525

Ejemplares similares

Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine
por: Soema, Peter C., et al.
Publicado: (2014)

Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance
por: Rosendahl Huber, Sietske K., et al.
Publicado: (2016)

Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses
por: Soema, Peter Christiaan, et al.
Publicado: (2015)

Solid Bioneedle-Delivered Influenza Vaccines Are Highly Thermostable and Induce Both Humoral and Cellular Immune Responses
por: Soema, Peter C., et al.
Publicado: (2014)

T Cell Responses to Viral Infections – Opportunities for Peptide Vaccination
por: Rosendahl Huber, Sietske, et al.
Publicado: (2014)

Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity
por: Rosendahl Huber, Sietske K., et al.
Publicado: (2019)

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
por: Kon, Theone C., et al.
Publicado: (2016)

Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets
por: Rosendahl Huber, S. K., et al.
Publicado: (2015)

Developments in the formulation and delivery of spray dried vaccines
por: Kanojia, Gaurav, et al.
Publicado: (2017)

Development of Thermostable Lyophilized Inactivated Polio Vaccine
por: Kraan, Heleen, et al.
Publicado: (2014)

Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults
por: van den Berg, Sara P. H., et al.
Publicado: (2018)

Latent CMV Infection Is Associated With Lower Influenza Virus-Specific Memory T-Cell Frequencies, but Not With an Impaired T-Cell Response to Acute Influenza Virus Infection
por: van den Berg, Sara P. H., et al.
Publicado: (2021)

Buccal and sublingual vaccine delivery
por: Kraan, Heleen, et al.
Publicado: (2014)

Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine
por: Kraan, Heleen, et al.
Publicado: (2016)

Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus
por: Westerhuis, Brenda, et al.
Publicado: (2020)

Publisher Correction: Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus
por: Westerhuis, Brenda, et al.
Publicado: (2020)

Influenza sequence and epitope database
por: Yang, Seok, et al.
Publicado: (2009)

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures
por: Geeraedts, Felix, et al.
Publicado: (2010)

Inactivation of Influenza Viruses with Heteropolyacids
por: Dalidchik, F. I., et al.
Publicado: (2022)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

THE INACTIVATION OF THE VIRUS OF EPIDEMIC INFLUENZA BY SOAPS
por: Stock, C. Chester, et al.
Publicado: (1940)

Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities
por: Amorij, J-P., et al.
Publicado: (2008)

2743. Safety of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine in Adults
por: Hansen, John, et al.
Publicado: (2019)

Associations and recovery dynamics of the nasopharyngeal microbiota during influenza-like illness in the aging population
por: Shetty, Sudarshan A., et al.
Publicado: (2022)

Characterization of Potent Fusion Inhibitors of Influenza Virus
por: Rowse, Michael, et al.
Publicado: (2015)

The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin
por: Shcherbinin, D.N., et al.
Publicado: (2016)

Epitope-targeting platform for broadly protective influenza vaccines
por: Zeigler, David F., et al.
Publicado: (2021)

Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients
por: Hovden, Arnt-Ove, et al.
Publicado: (2007)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults
por: Diazgranados, Carlos, et al.
Publicado: (2014)

PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity
por: Silva, A. L., et al.
Publicado: (2016)

Contribution of Influenza Viruses, Other Respiratory Viruses and Viral Co-Infections to Influenza-like Illness in Older Adults
por: Kaaijk, Patricia, et al.
Publicado: (2022)

Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018–2019 Influenza Season in the United States
por: Boikos, Constantina, et al.
Publicado: (2021)

Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach
por: Sun, Zhihao, et al.
Publicado: (2021)

Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines
por: Thommes, Edward W., et al.
Publicado: (2016)

Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines
por: van Essen, Gerrit A, et al.
Publicado: (2014)

Carriage of Streptococcus pneumoniae in Aged Adults with Influenza-Like-Illness
por: Krone, Cassandra L., et al.
Publicado: (2015)

Standardisation of inactivated influenza vaccines—Learning from history
por: Wood, John M., et al.
Publicado: (2018)

An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection
por: Ni, Yawei, et al.
Publicado: (2018)

Update of inactivated equine influenza vaccine strain in Japan
por: GAMOH, Koichiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_20giqmjcijab7ouq7r4hlqet38